Ninety One PLC (N91)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 199.00 |
|---|---|
| 52-week range | 196.08 – 262.20 |
| Return, 1 month / 3 months | −6.8% / −5.5% |
| Return, 1 year / 3 years | −2.6% / +53.2% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 27.1% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 165.43M GBX |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ninety One is an active asset management company based in London. It manages investments for institutional clients, financial advisers and individual savers across equity, fixed income, multi-asset and alternative strategies. The firm operates through offices in several countries and serves clients in markets around the world, offering both specialist and multi-asset portfolios. Its business centres on research-driven investment management and related client services.
The shares are listed on the London Exchange in UK under the code N91, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ninety One PLC (N91) trades on the London Exchange in UK. It last closed at GBX 199.00 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,435 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.6% and over the last three months it fell 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -23.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.5% | ||
| 6-month return | -6.1% | ||
| 12-month return, skipping the last month | 4.5% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 165.43M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 86 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −6.8% |
| 3 months | −5.5% |
| 6 months | −6.1% |
| 1 year | −2.6% |
| 3 years | +53.2% |
| 5 years | +5.5% |
Signals
| 50-day / 200-day average | 209.27 / 216.62 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.10 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | GBP 0.0740 |
| 4 Dec 2025 | GBP 0.0600 |
| 17 Jul 2025 | GBP 0.0680 |
| 12 Dec 2024 | GBP 0.0540 |
| 18 Jul 2024 | GBP 0.0640 |
| 7 Dec 2023 | GBP 0.0590 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.